JP2024523576A5 - - Google Patents
Info
- Publication number
- JP2024523576A5 JP2024523576A5 JP2023579654A JP2023579654A JP2024523576A5 JP 2024523576 A5 JP2024523576 A5 JP 2024523576A5 JP 2023579654 A JP2023579654 A JP 2023579654A JP 2023579654 A JP2023579654 A JP 2023579654A JP 2024523576 A5 JP2024523576 A5 JP 2024523576A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- imidazole
- isobutyl
- sulfonamide
- biphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2109946.0 | 2021-07-09 | ||
| GBGB2109946.0A GB202109946D0 (en) | 2021-07-09 | 2021-07-09 | New compounds |
| GB2202664.5 | 2022-02-25 | ||
| GBGB2202664.5A GB202202664D0 (en) | 2022-02-25 | 2022-02-25 | New compounds |
| PCT/GB2022/051760 WO2023281271A1 (en) | 2021-07-09 | 2022-07-08 | New selective angiotensin ii compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523576A JP2024523576A (ja) | 2024-06-28 |
| JP2024523576A5 true JP2024523576A5 (enExample) | 2025-07-15 |
Family
ID=82608432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579654A Pending JP2024523576A (ja) | 2021-07-09 | 2022-07-08 | 新規の選択的アンジオテンシンｉｉ化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20240262813A1 (enExample) |
| EP (1) | EP4367110A1 (enExample) |
| JP (1) | JP2024523576A (enExample) |
| KR (1) | KR20240035402A (enExample) |
| AU (1) | AU2022306778A1 (enExample) |
| CA (1) | CA3222721A1 (enExample) |
| CL (1) | CL2024000066A1 (enExample) |
| CO (1) | CO2024000096A2 (enExample) |
| IL (1) | IL309605A (enExample) |
| MX (1) | MX2024000518A (enExample) |
| WO (1) | WO2023281271A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3222721A1 (en) | 2021-07-09 | 2023-01-12 | Nadia Nasser PETERSEN | New selective angiotensin ii compounds |
| CN120569378A (zh) * | 2023-01-09 | 2025-08-29 | 维科尔药物公司 | 选择性血管紧张素ii化合物 |
| CN119504723A (zh) * | 2023-08-25 | 2025-02-25 | 武汉人福创新药物研发中心有限公司 | 作为at2r激动剂的噻吩磺酰基氨基甲酸酯 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464853A (en) | 1993-05-20 | 1995-11-07 | Immunopharmaceutics, Inc. | N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5198438A (en) | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5312820A (en) | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| NZ306734A (enExample) | 1995-04-04 | 2000-01-28 | Texas Biotechnology Corp | |
| US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
| SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| PT1094816E (pt) * | 1998-07-06 | 2009-03-10 | Bristol Myers Squibb Co | Sulfonamidas bifenílicas duplamente antagonistas receptores de angiotensina e endotelina |
| DE60222409T2 (de) | 2001-05-31 | 2008-09-25 | Vicore Pharma Ab | Trizyklische verbindungen, nützlich als angiotensin ii agonisten |
| JP4707321B2 (ja) * | 2001-05-31 | 2011-06-22 | ヴィコール・ファルマ・アーベー | アンギオテンシンｉｉアゴニストとして有用な三環式化合物 |
| WO2004046141A1 (en) | 2002-11-21 | 2004-06-03 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| BRPI0708507A2 (pt) * | 2006-03-03 | 2011-05-31 | Torrent Pharmaceuticals Ltd | Novos antagonistas de receptores de dupla ação (dara) para os receptores at1 eta |
| US8835471B2 (en) * | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| SG11201704473WA (en) | 2014-12-12 | 2017-06-29 | Vicore Pharma Ab | New methods and uses |
| WO2016107879A2 (en) | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
| AU2016227486A1 (en) | 2015-03-02 | 2017-08-17 | Vicore Pharma Ab | Angiotensin ll receptor agonist for treating pulmonary fibrosis |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201710906D0 (en) | 2017-07-06 | 2017-08-23 | Vicore Pharma Ab | Compounds and methods for treating peripheral neuropathy |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| PH12022552413A1 (en) * | 2020-03-19 | 2024-01-08 | Vicore Pharma Ab | Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin ii |
| CA3222721A1 (en) | 2021-07-09 | 2023-01-12 | Nadia Nasser PETERSEN | New selective angiotensin ii compounds |
-
2022
- 2022-07-08 CA CA3222721A patent/CA3222721A1/en active Pending
- 2022-07-08 EP EP22743876.9A patent/EP4367110A1/en active Pending
- 2022-07-08 US US18/577,856 patent/US20240262813A1/en active Pending
- 2022-07-08 AU AU2022306778A patent/AU2022306778A1/en active Pending
- 2022-07-08 MX MX2024000518A patent/MX2024000518A/es unknown
- 2022-07-08 JP JP2023579654A patent/JP2024523576A/ja active Pending
- 2022-07-08 IL IL309605A patent/IL309605A/en unknown
- 2022-07-08 KR KR1020237044464A patent/KR20240035402A/ko active Pending
- 2022-07-08 WO PCT/GB2022/051760 patent/WO2023281271A1/en not_active Ceased
-
2024
- 2024-01-08 CL CL2024000066A patent/CL2024000066A1/es unknown
- 2024-01-09 CO CONC2024/0000096A patent/CO2024000096A2/es unknown
- 2024-12-10 US US18/975,881 patent/US12441718B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022549086A5 (enExample) | ||
| JP2008513500A5 (enExample) | ||
| CN1906191A (zh) | 制备方法 | |
| JP2013519680A5 (enExample) | ||
| JP2007516173A5 (enExample) | ||
| JP2023539614A5 (enExample) | ||
| JP2013530240A5 (enExample) | ||
| JP2024528036A5 (enExample) | ||
| JP2013506637A5 (enExample) | ||
| CA2396824A1 (en) | Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 | |
| JP2007533752A5 (enExample) | ||
| JP2018522823A5 (enExample) | ||
| JP2005538955A5 (enExample) | ||
| JP2007520471A5 (enExample) | ||
| JP2010501587A5 (enExample) | ||
| JP2004532276A5 (enExample) | ||
| BR112014032956B1 (pt) | Processos para preparação de 1,2,4-oxadiazois 3,5-dissubstituídos | |
| JP2023518948A5 (enExample) | ||
| JP2013517279A5 (enExample) | ||
| JP2024511452A5 (enExample) | ||
| JP2005514432A5 (enExample) | ||
| JP2005526815A5 (enExample) | ||
| RU2004127928A (ru) | Производные морфолинилмочевины для использования в лечении воспалительных заболеваний | |
| JP2023021276A5 (enExample) | ||
| JP2004516295A5 (enExample) |